Posted on January 21, 2024
More than 40 million people in the United States,16 percent of all Americans over age 12 suffer from nicotine, alcohol, or drug addiction. Only about 10 percent of those people receive treatment, according to a recent report by the National Center on Addiction and Substance Abuse at Columbia University (CASA Columbia). And far fewer receive effective, evidence-based treatment, according to the report, entitled “Addiction medicine: Closing the gap between science and practice.”1
The previous three articles for Insights have focused on the brain and how drugs change it. The changes can be long-lasting and a brain on drugs is not normal. It wants more drugs. But just like drugs change the brain, abstinence and treatment can at least partially reverse the changes.2,3,4
Another problem is addicts have poor health. They have neglected the care of their body and mind.
They may have:
“I do not have a problem. I can stop any time I want. Do not call me an addict! Why should I stop? Drugs help me.”
Denying drug use allows them to do nothing and that can be a comforting frame of mind. They play the blame game (parents, bosses, illnesses, doctors and unfair treatment).
Self-loathing is common along with low self-esteem, guilt and shame.
The addict may come to realize what they have done to themselves and others. They may have tried to reverse course, but may have failed. They may sink lower and lower but are unable to stop it.
Confusion and fear of treatment
They may think that they will be:
People’s lives have been saved by timely treatment. The effectiveness of treatment is well documented.1
Why seek treatment
Does it always work for each and every person? A person in treatment for their addiction may require multiple rounds of treatments and may experience relapses before finding success. There may be those that drop out of treatment or never get adequate treatment.
Factors that predict success in treatment:
These factors seem to help, but people without these factors or characteristics have achieved success in their recovery.
The cost of treatment
Treatment may be free, low cost or on a sliding scale, but this depends upon insurance, treatment availability and patient resources.
Addicts cannot afford to not go into treatment.
This is a critical issue and has to do with society’s views and attitudes about addicts6:
There is a tendency for self-righteousness and moralizing in some groups!
Addiction research has shown that addiction is a brain-based disorder because of biological vulnerabilities and environmental factors.
From this perspective, drug abuse is similar to other diseases.
Addiction is like other chronic diseases. The literature review compared the diagnoses, heritability, etiology (genetic and environmental factors), pathophysiology, and response to treatments (adherence and relapse) of drug dependence vs type 2 diabetes mellitus, hypertension, and asthma.7
Genetic heritability, personal choice, and environmental factors are comparably involved in the etiology and course of all of these disorders.
Drug dependence produces significant and lasting changes in brain chemistry and function.
We should insure, treat and evaluate drug dependence, like other chronic illnesses.7
Principles of treatment
The National Institute on Drug Abuse identified these principles of treatment 8:
How do we define successful treatment?
When we say that treatment was a success, does it mean that the patient never takes the drug again? Is it total and permanent abstinence? That is certainly ideal and would be best. Historically, total abstinence has been the standard goal of treatment for substance use disorders involving methamphetamine and cocaine.
On January 10, 2024, NIH National Institute on Drug Abuse published a news release9: Reduced drug use is a meaningful treatment outcome for people with stimulant use disorder.
This study, published in Addiction, was led by scientists at the Johns Hopkins Bloomberg School of Public Health, Baltimore, in collaboration with researchers at the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.
This finding is according to an analysis of data from thirteen randomized clinical trials of treatments for stimulant use disorders involving methamphetamine and cocaine.
Researchers found that transitioning from high use (five or more days a month) to lower use (one to four days a month) was associated with lower levels of drug craving, depression, and other drug-related challenges compared to no change in use. These results suggest that reduction in use of methamphetamine or cocaine, in addition to abstinence, is a meaningful surrogate or intermediate clinical outcome in medication development for stimulant addiction. Unlike other substance use disorders, such as opioid use disorder or alcohol use disorder, there are currently no U.S. Food and Drug Administration-approved pharmacological treatments for stimulant use disorders.
“These findings align with an evolving understanding in addiction, affirming that abstinence should be neither the sole aim nor only valid outcome of treatment,” said NIDA Director Nora Volkow, M.D. “Embracing measures of success in addiction treatment beyond abstinence supports more individualized approaches to recovery, and may lead to the approval of a wider range of medications that can improve the lives of people with substance use disorders.”9
References
Written by Cynthia Blair RN MA–January 2024
Original Publication: https://www.soulsharbordallas.org/2024/01/seeking-treatment-2/
I’d love to hear about your health and medical writing needs. My goal is to create clear, accurate, and accessible medical content that informs, inspires, and empowers readers. Fill out the form below with the details of your project, and I’ll get back to you as soon as possible.